IRIDEX Cash Flow from Investing Activities 2010-2024 | IRIX
IRIDEX cash flow from investing activities from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
IRIDEX Annual Cash Flow Investing
(Millions of US $) |
| 2024 |
$0 |
| 2023 |
$0 |
| 2022 |
$0 |
| 2021 |
$-6 |
| 2020 |
$0 |
| 2019 |
$-1 |
| 2018 |
$-1 |
| 2017 |
$-1 |
| 2016 |
$-1 |
| 2015 |
$-1 |
| 2014 |
$-1 |
| 2013 |
$-1 |
| 2012 |
$-1 |
| 2011 |
$0 |
| 2010 |
$0 |
| 2009 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.018B |
$0.049B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
